US demand for pharmaceutical packaging will grow 5.5 percent annually through 2012. Strong growth is forecast for value-added types, especially parenteral vials and flip-top closures, plastic dispensing bottles and closures, prefillable inhalers and syringes, parenteral stoppers, track and trace and authentication labels, and unit dose pouches.
This study analyzes the $12.2 billion US drug packaging industry. It presents historical demand for the years 1997, 2002 and 2007, and forecasts for 2012 and 2017 by raw and semi-finished material (e.g., plastic, aluminum foil, paper and paperboard, glass); product (e.g., bottles, blister packs, parenteral containers, pouches, inhalers, medication tubes, closures, secondary containers, labels, inserts, wrap, seals, desiccants); and market.
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 32 industry players, including MeadWestvaco, Rexam and Alcan Packaging.